Global BioMEMS and Microsystem Market in Healthcare 2015-2019 with Bluechiip, Cepheid, Given Imaging & Integrated Sensing Systems Dominating

09 Nov, 2015, 12:10 ET from Research and Markets

DUBLIN, Nov. 09, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/f6ggnx/global_biomems) has announced the addition of the "Global BioMEMS and Microsystem Market in Healthcare 2015-2019" report to their offering.

The global BioMEMS and microsystems market in the healthcare sector to grow at a CAGR of 25.1% over the period 2014-2019.

BioMEMS assimilate miniature sensors, actuators, micro-optics, microfluidics, and structural elements with computation and controls for application in the healthcare sector. Microsystems are used in the healthcare sector for numerous applications. These devices improve the performance of medical devices by providing a competitive advantage to medical device manufacturers. For instance, the use of accelerometers has improved the treatment of cardiac diseases. Another instance being the use of MEMS and nanotechnology to improve drug delivery. The report includes a discussion of the key vendors operating in this market.

BioMEMS can be implanted into a specific region of the body for localized drug therapy. Once a drug is released into the body, the delivery system takes control of the dosage requirements, thus maximizing the effect of the drug and reducing the possibilities of side-effects. BioMEMS systems have sensors, which monitor the drug release profile and efficiency of the drug administered through specific marker molecules. Any regression of the disease being treated can be identified using these markers.

According to the report, rising healthcare costs have necessitated the increase in demand for health monitoring equipment, which are a cheaper alternative to traditional routine check-ups. Sensors can be installed around homes to keep track of daily activities, and any unusual change in activities is reported. Such sensors are also installed, albeit for a shorter period, to monitor sick patients. It provides accurate and reliable data, which helps in health evaluation. This technology can be highly beneficial for the aging population as they can undergo regular checkups and assistance can be provided in a timely manner.

Further, the report states that lack of awareness about BioMEMS is affecting the growth of the market.

Key vendors

  • Bluechiip
  • Cepheid
  • Given Imaging
  • Integrated Sensing Systems

Other prominent vendors

  • Becton, Dickinson and Co (BD)
  • Boston Scientific
  • CapitalBio
  • e2v
  • Heimann Sensor
  • Lepu Medical Technology
  • Mec
  • Micron Technology
  • Nanopass Technologies
  • OMRON
  • Teledyne DALSA
  • United Gene High-Tech Group

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by application

Part 07: Geographical segmentation

Part 08: Market Growth Drivers

Part 09: Impact of drivers

Part 10: Market challenges

Part 11: Impact of drivers and challenges

Part 12: Market trends

Part 13: Vendor landscape

Part 14: Key vendor analysis

Part 15: Appendix

For more information visit http://www.researchandmarkets.com/research/f6ggnx/global_biomems

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

SOURCE Research and Markets



RELATED LINKS

http://www.researchandmarkets.com